CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 161 filers reported holding CASTLE BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $343,948 | +21.6% | 20,364 | -1.2% | 0.00% | – |
Q2 2023 | $282,756 | +18.6% | 20,609 | +96.4% | 0.00% | – |
Q1 2023 | $238,424 | +3.1% | 10,494 | +6.9% | 0.00% | – |
Q4 2022 | $231,163 | -10.1% | 9,820 | 0.0% | 0.00% | – |
Q3 2022 | $257,000 | +28.5% | 9,820 | +7.8% | 0.00% | – |
Q2 2022 | $200,000 | -51.6% | 9,113 | -1.0% | 0.00% | – |
Q1 2022 | $413,000 | +7.3% | 9,207 | +2.5% | 0.00% | – |
Q4 2021 | $385,000 | -35.4% | 8,984 | +0.3% | 0.00% | – |
Q3 2021 | $596,000 | +60.2% | 8,956 | +76.9% | 0.00% | – |
Q2 2021 | $372,000 | +33.3% | 5,062 | +24.3% | 0.00% | – |
Q1 2021 | $279,000 | +118.0% | 4,072 | +113.2% | 0.00% | – |
Q4 2020 | $128,000 | +30.6% | 1,910 | 0.0% | 0.00% | – |
Q3 2020 | $98,000 | +53.1% | 1,910 | +13.0% | 0.00% | – |
Q2 2020 | $64,000 | +48.8% | 1,691 | +16.1% | 0.00% | – |
Q1 2020 | $43,000 | +79.2% | 1,457 | +111.5% | 0.00% | – |
Q4 2019 | $24,000 | +140.0% | 689 | +19.6% | 0.00% | – |
Q3 2019 | $10,000 | – | 576 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |